Top Texas Lawmakers Say Medical Marijuana Expansion Is On The Table For 2021

As Texas lawmakers returned to work for a new session this week, leaders of both chambers of the state’s legislature said they expect to see action on marijuana bills this year, particularly when it comes to expanding the state’s limited medical cannabis program.

Read more

Cybin announces the API synthesis of multiple tryptamine derivatives.

Read more
New York Governor Calls For Marijuana Legalization In State Of The State Address

New York Gov. Andrew Cuomo (D) on Monday again discussed the need to legalize marijuana in 2021.

Read more
Might a safer version of a psychedelic help treat depression?

Research in animals suggests that the new compound is neither toxic nor hallucinogenic and that it may help treat a range of psychiatric disorders, including depression and addiction, and possibly anxiety and post-traumatic stress disorder (PTSD).

Read more
Cannabis Sales Surpass $1B In Illinois

Combined adult-use and medical cannabis sales topped $1 billion in Illinois, with recreational sales nearing $670 million and medical sales reaching $331 million. Adult-use sales launched in the state on Jan. 1, 2020.

Read more
Why Canada Could Be Next To Allow Psychedelic Therapy (And How It’s Already Changing Lives)

Canada has an international reputation for progressive health policies, take for example its publicly funded healthcare program and its assisted dying laws. It also led the way in drug reform when it became the first G7 country to legalize cannabis in 2018. 

Read more
Will psychedelic mushroom vacations come to the U. S.?

The palm-fringed beachfront and breezy cabanas at MycoMeditations are the stuff of glossy travel brochures, but the barefoot vacationers roaming the Jamaican retreat center this winter are seeking a different kind of trip entirely.

Read more
Mind Cure Announces Build-Out of Digital Therapeutics,iSTRYM: A Technology Platform for Mental Wellness Optimization & PsychedelicResearch

Mind Cure’s iSTRYM digital therapeutics platform is designed to provide real-time data regarding patient care.

Read more
Will ATAI IPO Be The First Major Psychedelics Catalyst For 2021?

The ATAI Life Sciences IPO could come as soon as the end of January. What does this mean for psychedelic stock investors?

Read more
MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m) to Meet High Investor Demand

MindMed closes on a CAD$92.1 million financing from what was originally a $50 million offering. Total cash on hand increases to US$144.4 million.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )